Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Pulmonary Embolism Management
Author(s): Andrew SP Sharp, Mantas Buitkus, Gilles Lemesle Start date: Oct 07, 2025
Pulmonary Embolism (PE) remains a leading cause of cardiovascular morbidity and mortality, requiring timely intervention and coordinated multidisciplinary care. This session will provide an in-depth analysis of the current PE treatment landscape, including the latest clinical trial updates (HI-PEITHO, PEERLESS), institutional decision-making workflows and collaborative patient management… View more

Intervention

Vascular Disease and Surgery
Recent Advances in Pulmonary Hypertension
Author(s): Akshyaya Pradhan , Richa Tyagi , Prachi Sharma , et al Added: 1 year ago

Heart Failure

Prevention & Chronic Conditions
Left Main Disease: The Last Frontier for Medical Therapy in Stable CAD?
Author(s): Armin Arbab-Zadeh , Michelle Graham , Hector M Garcia-Garcia , et al Added: 5 months ago

Intervention

Prevention & Chronic Conditions
ESC 25 Discussion: 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
Author(s): Harriette Van Spall , Michael Andrew Borger Added: 5 months ago
ESC Congress 2025 - Dr Harriette Van Spall (McMaster University, Canada) sits down with Professor Michael Borger (University of Leipzig Heart Center, Germany), Co-Chair of the newly released 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease.The new guidelines bring together the latest evidence and expert consensus on how to diagnose, evaluate, and treat patients with valvular… View more

Guidelines & Statements

Imaging & Diagnostics
Uric Acid Metabolism in the Pathophysiology of Ischaemic Heart Disease
Author(s): Federica Piani , Lorenzo Annesi , Claudio Borghi Added: 8 months ago

Heart Failure

Prevention & Chronic Conditions
TMVR in Patients with Multivalvular Heart Disease with Dr Kimberly Holst
Author(s): Kimberly Holst Added: 3 months ago
Navigate the strategic complexities of transcatheter mitral valve replacement in multivalvular disease with Dr Kimberly HolstThis presentation, part of Women As One's comprehensive Structural Interventions track, provides a systematic framework for approaching multivalvular heart disease. The presentation establishes the foundational principle of strategic intervention sequencing in high-risk… View more

Intervention
2024 ESC Guidelines on Peripheral Arterial and Aortic Diseases
Author(s): Giuseppe Ferrante , Brittany A Bacallao , Francesco Gioia , et al Added: 1 year ago

Vascular Disease and Surgery
ESC 25 Guidelines Discussion: Management of Cardiovascular Disease and Pregnancy
Author(s): Harriette Van Spall , Julie De Backer Added: 4 months ago
ESC Congress 2025 - Late-breaker host Dr Harriette Van Spall (McMaster University, CA) joins Prof Julie De Backer (University Hospital Ghent, BE) to discuss the newly released 2025 ESC Guidelines for the Management of Cardiovascular Disease in Pregnancy. Together, they highlight key updates, critical advances in maternal cardiovascular care, and evidence-based recommendations tailored for this… View more

CV Disease in Special Populations

Guidelines & Statements
Cardiac Troponins in Kidney Disease
Author(s): Daniel Murphy , Debasish Banerjee Added: 6 months ago

Heart Failure
ERA 25: Albuminuria, eGFR Dip and Disease Severity & Empagliflozin
Author(s): William Herrington Added: 8 months ago
ERA 2025 - Findings from a meta-analysis of chronic kidney disease outcomes in patients treated with empagliflozin suggest that people with CKD benefit from the drug irrespective of diabetes of albuminuria status.ProfWilliam Herrington (University of Oxford, Oxford, UK) joins us to discuss outcomes from an individual patient-level data meta-analysis, investigating the impact of diabetes,… View more

Cardiovascular Renal Metabolic